Drug intelligence / Profile preview

Propofol, Benzodiazepine, and Opioid Combination

Development stage
Unknown
Lead developer
COSMO GROUP
Modality
Device-based Delivery → Drug Delivery Systems
Administration
Intravenous
01

Overview

This is a combination of three different drug classes that is sometimes used together for sedation, particularly during endoscopic procedures. The combination includes propofol (an anesthetic agent), benzodiazepines (sedatives), and opioids (pain medications). According to the search results, this combination is used in clinical practice for sedation during procedures, though there are important safety considerations. The search results indicate that propofol used alone or in combination with benzodiazepines and/or opioids appears to be safe for endoscopic procedures when properly administered[3]. There was a trend toward increased incidence of bradycardia in patients receiving propofol with benzodiazepine and opioid sedation compared to those on propofol alone, though this difference was not statistically significant[3]. The combination is used to obtain adequate depth of sedation while potentially avoiding high dose-related side effects of propofol alone[3]. It's important to note that combining opioids with benzodiazepines generally carries significant risks, as both drug classes can cause sedation and respiratory depression[1][2]. This combination requires careful monitoring and appropriate medical supervision. The specific drugs that might be used in this combination could include: - Propofol (anesthetic) - Benzodiazepines such as diazepam (Valium), alprazolam (Xanax), clonazepam (Klonopin), or midazolam - Opioids such as fentanyl, morphine, or hydrocodone This combination would typically be administered in controlled medical settings such as hospitals or endoscopy centers under the supervision of anesthesiologists or other qualified healthcare providers.

02

Targets

GABRR (GABA-A receptor subunit rho)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on Propofol, Benzodiazepine, and Opioid Combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Propofol, Benzodiazepine, and Opioid Combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call